Waiting is the Hardest (W.I.T.H Podcast 🎙)

Double Bonus continued: An Interview with Pediatric Hematologist, Dr. Gregory Yanik PART 2

April 22, 2023 Season 2 Episode 11
Double Bonus continued: An Interview with Pediatric Hematologist, Dr. Gregory Yanik PART 2
Waiting is the Hardest (W.I.T.H Podcast 🎙)
More Info
Waiting is the Hardest (W.I.T.H Podcast 🎙)
Double Bonus continued: An Interview with Pediatric Hematologist, Dr. Gregory Yanik PART 2
Apr 22, 2023 Season 2 Episode 11

We wrap up our conversation with Dr. Gregory Yanik, Director of the Pediatric Blood and Marrow Transplant Program at the University of Michigan Medical Center in Ann Arbor, Michigan. 

Parts 1 and 2 of this double bonus episode is a must-listen for every patient, family, and doctor in the healthcare field.  Dr. Yanik epitomizes a model of compassion and respect for families and patients that every healthcare center should replicate and implement ASAP. 

This episode covers graft versus host disease, patient advocacy, the latest in half and full-match bone marrow transplant options for patients with sickle cell anemia, gene editing, recently completed studies from the Bone Marrow Transplant Clinical Trial Network, and much more!

Show Notes Chapter Markers

We wrap up our conversation with Dr. Gregory Yanik, Director of the Pediatric Blood and Marrow Transplant Program at the University of Michigan Medical Center in Ann Arbor, Michigan. 

Parts 1 and 2 of this double bonus episode is a must-listen for every patient, family, and doctor in the healthcare field.  Dr. Yanik epitomizes a model of compassion and respect for families and patients that every healthcare center should replicate and implement ASAP. 

This episode covers graft versus host disease, patient advocacy, the latest in half and full-match bone marrow transplant options for patients with sickle cell anemia, gene editing, recently completed studies from the Bone Marrow Transplant Clinical Trial Network, and much more!

Graft v Host disease risks
What is Graft versus Host Disease (GVHD)
CORRECTION: GVHD is inflammation NOT rejection
Types of GVHD
Rejection rates: Sickle Cell Disease and Transplant
Research studies
Bone Marrow Transplant Clinical Trial Network (BMTCTN)
Completing the patient care puzzle: Patient advocacy
Adult patients with sickle cell anemia
Gene editing
DNA scissors
Fetal hemoglobin
Dr. Yanik's words of encouragement